All Names: Tecfidera
Indications:multiple sclerosis (MS)
Manufacturer:Biogen, USA
Customs Clearance Procedure:If the customs requires the package for customs clearance, please pay the customs clearance fee according to the content of EMS SMS and customs regulations.
INDICATIONS AND USAGE
TECFIDERA is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
DOSAGE
Dosing Information
The starting dose for TECFIDERA is 120 mg twice a day orally. After 7 days, the dose should be increased to the maintenance dose of 240 mg twice a day orally. Temporary dose reductions to 120 mg twice a day may be considered for individuals who do not tolerate the maintenance dose. Within 4 weeks, the recommended dose of 240 mg twice a day should be resumed. Discontinuation of TECFIDERA should be considered for patients unable to tolerate return to the maintenance dose. The incidence of flushing may be reduced by administration of TECFIDERA with food. Alternatively, administration of non-enteric coated aspirin (up to a dose of 325 mg) 30 minutes prior to TECFIDERA dosing may reduce the incidence or severity of flushing.
TECFIDERA should be swallowed whole and intact. TECFIDERA should not be crushed or chewed and the capsule contents should not be sprinkled on food. TECFIDERA can be taken with or without food.
ADVERSE REACTIONS
Anaphylaxis and Angioedema
Progressive multifocal leukoencephalopathy
Herpes Zoster and Other Serious Opportunistic Infections
Lymphopenia
Liver Injury
Flushing
For full information, please refer to:
https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/665d7e74-036c-5f68-5b67-ab84b9b49151/spl-doc?hl=Tecfidera
Tecfiderainformation
No information yet!!!